TrialThe American journal of cardiology2004

Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.

Theodore Feldman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.